VEGFA and breast cancer: After real-time intraoperative detection of breast cancer using non-specific fluorescence probes such as methylene blue [32] and indocyanine green [33], Lamberts et al. [34] introduced in 2017 the VEGF-A targeting antibody bevacizumab-IRDye800CW.